Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder
- PMID: 19360663
- PMCID: PMC2678909
- DOI: 10.1002/aur.27
Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder
Abstract
A functional promoter variant of the gene encoding the MET receptor tyrosine kinase alters SP1 and SUB1 transcription factor binding, and is associated with autism spectrum disorder (ASD). Recent analyses of postmortem cerebral cortex from ASD patients revealed altered expression of MET protein and three transcripts encoding proteins that regulate MET signaling, hepatocyte growth factor (HGF), urokinase plasminogen activator receptor (PLAUR) and plasminogen activator inhibitor-1 (SERPINE1). To address potential risk conferred by multiple genes in the MET signaling pathway, we screened all exons and 5' promoter regions for variants in the five genes encoding proteins that regulate MET expression and activity. Identified variants were genotyped in 664 families (2,712 individuals including 1,228 with ASD) and 312 unrelated controls. Replicating our initial findings, family-based association test (FBAT) analyses demonstrated that the MET promoter variant rs1858830 C allele was associated with ASD in 101 new families (P=0.033). Two other genes in the MET signaling pathway also may confer risk. A haplotype of the SERPINE1 gene exhibited significant association. In addition, the PLAUR promoter variant rs344781 T allele was associated with ASD by both FBAT (P=0.006) and case-control analyses (P=0.007). The PLAUR promoter rs344781 relative risk was 1.93 (95% confidence interval [CI]: 1.12-3.31) for genotype TT and 2.42 (95% CI: 1.38-4.25) for genotype CT compared to genotype CC. Gene-gene interaction analyses suggested a significant interaction between MET and PLAUR. These data further support our hypothesis that genetic susceptibility impacting multiple components of the MET signaling pathway contributes to ASD risk.
Figures
Similar articles
-
Disruption of cerebral cortex MET signaling in autism spectrum disorder.Ann Neurol. 2007 Sep;62(3):243-50. doi: 10.1002/ana.21180. Ann Neurol. 2007. PMID: 17696172
-
Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions.Pediatrics. 2009 Mar;123(3):1018-24. doi: 10.1542/peds.2008-0819. Pediatrics. 2009. PMID: 19255034
-
A genetic variant that disrupts MET transcription is associated with autism.Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16834-9. doi: 10.1073/pnas.0605296103. Epub 2006 Oct 19. Proc Natl Acad Sci U S A. 2006. PMID: 17053076 Free PMC article.
-
The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders.J Clin Invest. 2009 Apr;119(4):747-54. doi: 10.1172/JCI37934. Epub 2009 Apr 1. J Clin Invest. 2009. PMID: 19339766 Free PMC article. Review.
-
MET receptor tyrosine kinase as an autism genetic risk factor.Int Rev Neurobiol. 2013;113:135-65. doi: 10.1016/B978-0-12-418700-9.00005-8. Int Rev Neurobiol. 2013. PMID: 24290385 Free PMC article. Review.
Cited by
-
Autism-specific maternal anti-fetal brain autoantibodies are associated with metabolic conditions.Autism Res. 2017 Jan;10(1):89-98. doi: 10.1002/aur.1657. Epub 2016 Jun 17. Autism Res. 2017. PMID: 27312731 Free PMC article.
-
Neurobiology meets genomic science: the promise of human-induced pluripotent stem cells.Dev Psychopathol. 2012 Nov;24(4):1443-51. doi: 10.1017/S095457941200082X. Dev Psychopathol. 2012. PMID: 23062309 Free PMC article.
-
Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility.Exp Neurol. 2010 Jan;221(1):129-35. doi: 10.1016/j.expneurol.2009.10.011. Epub 2009 Oct 22. Exp Neurol. 2010. PMID: 19853606 Free PMC article.
-
Identification of a Novel Small RNA Encoded in the Mouse Urokinase Receptor uPAR Gene (Plaur) and Its Molecular Target Mef2d.Front Mol Neurosci. 2022 Jul 6;15:865858. doi: 10.3389/fnmol.2022.865858. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35875662 Free PMC article.
-
Interaction between GSTT1 and GSTP1 allele variants as a risk modulating-factor for autism spectrum disorders.Res Autism Spectr Disord. 2015 Apr 1;12:1-9. doi: 10.1016/j.rasd.2014.12.008. Res Autism Spectr Disord. 2015. PMID: 25685181 Free PMC article.
References
-
- Allgayer H. Regulation and clinical significance of urokinase-receptor (u-PAR), an invasion-related molecule. Zeitschrift fur Gastroenterologie. 2006;44:503–511. - PubMed
-
- Campbell DB, D'Oronzio R, Garbett K, Ebert PJ, Mirnics K, Levitt P, et al. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Annals of Neurology. 2007;62:243–250. - PubMed
-
- Centers for Disease Control and Prevention Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002. Morbidity and Mortality Weekly Report: Surveillance Summaries. 2007;56:12–28. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous